Adiponectin protects against the development of systolic dysfunction following myocardial infarction. - Wikidata - awgldk - TriplyDB

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

http://www.wikidata.org/entity/Q36004798

about

Differential Role of Leptin and Adiponectin in Cardiovascular System Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease Adipocytokines and obesity-linked disorders Cardiometabolic effects of adiponectin Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo.Adipokines in inflammation and metabolic disease Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction.Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2.T-cadherin is critical for adiponectin-mediated cardioprotection in mice.Adiponectin provides cardiovascular protection in metabolic syndrome.Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction.Adiponectin increases secretion of rat submandibular gland via adiponectin receptors-mediated AMPK signaling.Gender differences in adiponectin modulation of cardiac remodeling in mice deficient in endothelial nitric oxide synthase.Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes.Adiponectin protects rat myocardium against chronic intermittent hypoxia-induced injury via inhibition of endoplasmic reticulum stress.Adiponectin in cardiovascular inflammation and obesity Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart.Temporal and Molecular Analyses of Cardiac Extracellular Matrix Remodeling following Pressure Overload in Adiponectin Deficient Mice Adiponectin receptor signalling in the brain Long-Lived αMUPA Mice Show Attenuation of Cardiac Aging and Leptin-Dependent Cardioprotection.Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions?AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy.Adiponectin action: a combination of endocrine and autocrine/paracrine effects.The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox".Association between adiponectin and heart failure risk in the physicians' health study.Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model.Secreted Frizzled-related Protein 5 Diminishes Cardiac Inflammation and Protects the Heart from Ischemia/Reperfusion Injury.Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes.Adiponectin promotes endothelial progenitor cell number and function.Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model.Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction.Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure.

P2860

Q26864590-63169C33-9BA6-4D56-B526-F91EA5F8ACB3 Q27010136-2E572C45-14C8-4159-9821-BF6A2C2FE1D7 Q27021977-AC84D32C-F4FC-41F2-82CD-3202919221E6 Q27027840-387EDA65-17CE-41E7-B14C-0C1732FB37D2 Q28238431-5E1BFC19-D155-4F0A-A871-4DF8285B2F78 Q28583791-9AE85411-5D28-4049-987B-A419AAFA4373 Q28591569-4D76AAF2-70F3-4CB8-9FD6-84C07874F930 Q29620456-90FECABC-D70B-4305-9086-EE7046E604CC Q33511929-44BA0FE2-8DBE-41DD-8BE1-C027D3D36E93 Q33639520-AA10671A-BE64-45AC-94FA-81660B31A075 Q33839167-2E6AAEFB-E2E6-485E-B1B4-843931EACCE5 Q33912715-15B40D74-215F-4041-9888-FFF4C0D0567B Q33937192-2E2BF5CF-B156-4452-8616-56300A5EFEE2 Q34360180-9D2B9EFA-574D-49B7-BF40-2B2F729E3949 Q34557564-61BCED45-D6A1-4A75-9C9A-20DFFB8DAC13 Q34559877-D5B9CB52-F901-4EDA-8B78-801205A210D5 Q34718458-0C31CE53-A303-46AB-A451-63E18D6AA93A Q34721083-895133FF-174A-48B3-8164-825AF53869E1 Q34873021-EC0907FE-A8C1-41D1-AA65-B1492D70E622 Q35144190-BAA567A0-CDE8-4E8A-8AA6-76D3CDCACBD3 Q35219362-140A01AB-4859-4E83-81AB-36B8653679A6 Q35315318-5206CFF1-711E-47D8-AA62-F3A494F31500 Q35528402-4B0B1DFB-86B4-4BAB-AAAB-5807FAC15FA2 Q35614083-DE6645DD-D4C2-4525-9333-DCF918A44121 Q35708104-B1A5E2D9-015C-4715-AC7F-12DDA161331D Q35870187-CF2CB4DF-736B-4CA4-BEED-3CEF8CE79F3A Q35896190-4B7D1E08-C850-4C7B-AD6C-DACCC4C7C4D4 Q35916840-45FE88D0-8A68-4C58-BAE2-D990D5B6D0E5 Q35965049-1DF43F08-8692-42A2-9DB2-49D971788F86 Q35971216-B83CE07F-7335-4437-9795-8D9FCAC58D13 Q36274270-F6404C3E-6E42-41DF-8151-163B28B47C56 Q36341930-CD1A493E-AB1A-461D-963B-98C184B97194 Q36510256-33F1AA04-F6C6-44B4-9928-96D2448E1D66 Q36548318-786B927D-A41A-4FF6-B254-C4099AD8E379 Q36710970-29FE44D7-4A11-4B22-88A0-631BFC71113F Q36732342-4B2E5320-2DB2-405E-AC58-AAE6E98AE958 Q36890479-D3AB8615-B841-46C5-BC49-760FC5052539 Q36895921-7C975B8D-DA52-431F-B0DF-17BC5EAD5BE4 Q36975496-43A57906-A71A-4DB8-88B5-E4203B1448A0 Q36996413-A299AE19-C4A1-4BFB-8649-87D18BB41BA4

P2860

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

http://www.wikidata.org/entity/Q36004798

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Adiponectin protects against t ...... llowing myocardial infarction.

@ast

Adiponectin protects against t ...... llowing myocardial infarction.

@en

type

label

Adiponectin protects against t ...... llowing myocardial infarction.

@ast

Adiponectin protects against t ...... llowing myocardial infarction.

@en

prefLabel

Adiponectin protects against t ...... llowing myocardial infarction.

@ast

Adiponectin protects against t ...... llowing myocardial infarction.

@en

P1433

Q36004798-26044052-F961-409A-A8D2-F75B9283B44D

P1476

Q36004798-D73954F8-116B-4680-9EEF-1F481FE5DE9C

P2093

Q36004798-520A1251-9B7B-4E1A-8BAC-A0EA10EC0A88

Q36004798-58BA92C6-64A5-4552-AF53-ED748C047862

Q36004798-9A4314A1-EA94-4237-B42B-C333330B2D3E

Q36004798-C4065C8F-FC02-4601-812A-2F0D09902A98

Q36004798-DE03E73F-E890-4CF7-98CE-EED97AA4C2AE

Q36004798-EADA201B-AF68-4F2E-9B92-3A404F0A03D4

Q36004798-EB202A71-9A2E-4EB0-9017-0BFD33B0CAEC

Q36004798-F0AB5414-6F5E-4570-86EE-81A8AAEB43B1

P2860

Q36004798-0542F237-4BAE-4BB0-A1D8-4E8D45E68D3D

Q36004798-073B8CC9-ABAC-4ACC-A95C-15C459557A25

Q36004798-1C4DE6C2-2EE5-4B38-BE7D-CA83A28A9D79

Q36004798-1DC48CF0-7C9C-4C5F-833C-ECAA4437DF15

Q36004798-23136EA1-F744-43AB-9B06-27DCBDC758C2

Q36004798-24488B84-17CE-4476-9999-A895CBCF76A0

Q36004798-2B4F3D2C-7A32-4DEA-B656-C9171A5B8B1E

Q36004798-349F0D26-1349-4028-AA1F-C283A4855C2B

Q36004798-3558B86D-EB6D-426C-A182-411634E58597

Q36004798-40883D40-2280-4C8A-BAF0-E0792CBC33A5

P304

Q36004798-332AA7D5-AEF7-4AF0-BB11-06E53DBFD667

P31

Q36004798-2DBCC8E4-EB2B-4317-8097-706F1C7FC6FE

P356

Q36004798-644BA0F8-FFCD-4B0D-B403-910E886D3948

P433

Q36004798-C9BC8B71-42C9-4547-BD75-9052877CF396

P478

Q36004798-14728B11-A9EE-4284-8F71-E2E45435A254

P50

Q36004798-B9D82DE2-542B-45A3-837A-F9E258816AA0

P577

Q36004798-4537E4BA-A40D-4537-BC0E-D5A9663E7865

P5875

Q36004798-9922621E-0537-4C07-A262-55E95EB297BB

P698

Q36004798-4AFC1952-78C4-4A41-9029-291B77C45208

P921

Q36004798-6F5214E3-1E56-4A22-9B1F-DA235E55C470

Q36004798-93AE9816-C671-44AB-86E2-23C877CEBB4F

P932

Q36004798-FD79ABE3-38C0-4835-9636-CE89B314A6DF

P356

J.YJMCC.2007.03.808

P1433

Journal of Molecular and Cellular Cardiology

P1476

Adiponectin protects against t ...... ollowing myocardial infarction

@en

P2093

Kaori Sato

http://www.w3.org/2001/XMLSchema#string

Kenneth Walsh

http://www.w3.org/2001/XMLSchema#string

Kyriakos Papanicolaou

http://www.w3.org/2001/XMLSchema#string

Noriyuki Ouchi

http://www.w3.org/2001/XMLSchema#string

Rei Shibata

http://www.w3.org/2001/XMLSchema#string

Shinji Kihara

http://www.w3.org/2001/XMLSchema#string

Wilson S Colucci

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Izumiya

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Obesity and the risk of heart failure

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart

A novel serum protein similar to C1q, produced exclusively in adipocytes

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling.

Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart.

Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.

Adiponectin-mediated modulation of hypertrophic signals in the heart

P304

1065-1074

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YJMCC.2007.03.808

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6331903

http://www.w3.org/2001/XMLSchema#string

P698

17499764

http://www.w3.org/2001/XMLSchema#string

P921

P932

1987393

http://www.w3.org/2001/XMLSchema#string